Skip to content

Clinical trials

Completed Psychotic Disorders trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Status: Completed Country / region: Australia Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20021
20031
20042
20052
20062
20072
20101
20112
20121
20151
20161

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Alfred6
Melbourne Health4
Bayside Health3
Eli Lilly and Company2
The University of New South Wales2
AstraZeneca1
Orygen1
Rene Kahn1
Swinburne University of Technology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders21
Schizophrenia13
Mental Disorders5
Bipolar Disorder3
Mania2
Mood Disorders2
Affective Disorders, Psychotic1
Anxiety Disorders1
Attention Deficit and Disruptive Behavior Disorders1
Obesity1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.